Search results
Novavax shares jump 40% on $1.2 billion licensing deal with Sanofi despite Q1 losses | Invezz
Invezz· 2 days agoNovavax (NASDAQ:NVAX) shares rocketed 40% in premarket trading Friday, driven not only by the...
Maryland-based Novavax soars on big vaccine deal - WTOP News
WTOP Washington· 2 days agoGaithersburg, Maryland-based Novavax has signed a $1.2 billion licensing agreement with French...
Novavax stock doubles after Sanofi deal marks 'new chapter' for company
AOL· 1 day agoNovavax stock (NVAX) skyrocketed on Friday, nearly doubling on the news French drug and vaccine giant Sanofi (SNY) would invest $1.2 billion in a deal for ...
Novavax shares soar on license deal with Sanofi at lofty valuation
Reuters· 1 day ago, opens new tab for its COVID-19 vaccine in exchange for a stake that valued the U.S. biotech firm...
Novavax Soars on $1.2 Billion Sanofi Vaccine Licensing Deal
Bloomberg· 2 days agoHave a confidential tip for our reporters? Novavax Inc. shares surged after the company signed a...
Novavax Stock Doubles on $1.2B Sanofi Deal for COVID-19, Flu Vaccines
Investopedia· 2 days agoSanofi agreed to pay Novavax $500 million upfront, with another $700 million in possible payments...
Novavax Sheds Going Concern Warning as NVAX Stock Pops on Sanofi Licensing Deal
InvestorPlace· 2 days agoThe agreement will also provide Sanofi with a sole license to the vaccine for use in combination...
Novavax Shares Surge on $1.4 Billion Vaccine Licensing Deal with Sanofi
Market Watch· 2 days agoBy Dean Seal Shares of Novavax surged after the company disclosed a $1.4 billion licensing deal with Sanofi. The stock was up 72% at $7.66 in premarket...
The Sanofi-Novavax vaccine deal is worth up to $1.2 billion
The Port Lavaca Wave· 2 days agoThe Sanofi-Novavax vaccine deal is worth up to $1.2 billion
Novavax Shares Surge on $1.4 Billion Vaccine Licensing Deal with Sanofi
Morningstar· 2 days agoThe stock was up 72% at $7.66 in premarket trading on Friday. The vaccine maker said overnight that it has reached a licensing agreement with Sanofi to jointly commercialize ...